Twenty percent of the population suffers from some sort digestive issue, it is epidemic in size. Our GI panel was developed to identify the most common pathogenic bacteria, parasites, and viruses in the stool. It also includes critical information about specific GI functions which can determine the difference between Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). No endoscopy or colonoscopy is required. Patients collect the specimen in the privacy of their home. This is State-of-the-Art PCR based testing with unparalleled sensitivity and specificity.
Digestive System Challenges
A Diagnostician’s Dilemma
Do you ever reach a point in the diagnostic process and say “Now what do I do?” This might happen only a couple of times a month. It could be happening daily with your patients. You need some idea of what is going on so you can find a course of treatment. What do you do when nothing you have tried solves the patient’s problem? If you have run every test in your arsenal and performed every procedure you can think of, then you are reduced to managing a patient’s symptoms with drugs for the long haul.
There is another option
When your patient’s complaint is digestive, there is a next step: the GI Pathogens Plus Profile. It gives a complete picture of your patient’s digestive health. Invasive procedures or stool cultures are not suited to accurately identify most pathogenic bacteria or parasites that impact the digestive system. The PCR based GI Pathogens Plus Profile test is. PCR technology provides the ability to identify bacteria, parasites, and fungi regardless of their viability in the sample giving you a true representation of all of the things contributing to your patient’s symptoms. You get a clearer picture of what is really bugging your patients. Stool cultures grow only aerobic bacteria. Ninety-five percent of the bacteria in the digestive system are anaerobic, including the pathogens! Parasites need to be in high numbers to be detected by microscopy. All of this makes the results from a culture and O&P test questionable at best and potentially misleading at worst.
Patients’ Access to Test Reports (CMS-2319-F)
DRG must honor all properly made, HIPAA compliant requests for personal results once 7 days from the date DRG released the results has passed. Any questions on this policy, please contact the Lab directly.
Specimens received without proof of acceptable payment (e.g., insurance information, proof of cash payment) will not be run until full payment is secured, and will be maintained in our Missing Pertinent Information (MPI) storage. If the information is not received by 8 calendar days from receipt, the specimen will be disposed of. Only one initial form of payment will be accepted for each individual specimen. We kindly request that all specimens be submitted with payment information finalized prior to submitting the specimen, or the above conditions apply. If the patient has paid cash for their bill then the account is deemed settled and it is closed. DRG will be happy to provide a statement or bill for any patient who wishes to settle their account with the laboratory; kindly ask our helpful customer service team for this information.
- 23.1% of all specimens had Bacteria
- 35.2% of all specimens had actionable Lactoferrin levels
- 46.4% of all specimens had a Bacteria, Parasite or Virus
- 48.2% of all specimens had 2 or more
- 70.3% of all specimens had actionable Secretory IgA
- 97.6% of all specimens with Bacteria had Antibiotic Resistance to a Class of Drugs
Overall, more than 80% of all specimens had actionable information for the physician
- K92.89/B96.81 – Other spec. diseases of digestive system / H. pylori
- R19.7 – Diarrhea
- K59.00 – Constipation, unspecified
- R10.9 – Abdominal pain
- K59.9 – Unspecified functional disorder of intestine
- R10.13 – Dyspepsia/other specified disorders of stomach function
- K58.0 – Irritable Bowel Syndrome (IBS)
- K29.00 – Acute gastritis without bleeding
- R14.0 – Flatulence, eructation and gas pain (.0 or .1 or .3)
- K21.9 – Gastro-esophageal reflux disease without esophagitis
- K59.1 – Functional diarrhea